29786-42-3

Usage

Uses

Used in Organic Synthesis:
1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile is used as an intermediate in organic synthesis for its structural features and potential reactivity, which can be exploited to create a variety of other compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile is used as a building block for the development of new drugs, leveraging its unique structural properties to design molecules with specific biological activities.
Used in Materials Science:
1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile is also used in materials science as a component in the development of novel materials, taking advantage of its structural characteristics to enhance material properties such as strength, flexibility, or chemical resistance.
(Note: The specific uses and properties of 1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile would need to be determined through further research and testing, as the provided materials do not detail its exact applications.)

Upstream product

• 78-75-1 1,2-Dibromopropane 
• 3038-47-9 2-(trifluoromethyl)phenylacetonitrile 
• 109-64-8 1,3-dibromo-propane 

Downstream Products

• 940868-59-7 1-(2-(trifluoromethyl)phenyl)cyclobutanecarbaldehyde 
• 29786-27-4 (<1-(α,α,α-Trifluoro-o-tolyl)cyclobutyl>carbonyl)carbamsaeureethylester 
• 29786-22-9 (<1-(α,α,α-Trifluoro-o-tolyl)cyclobutyl>carbonyl)carbamsaeuremethylester 
• 29770-38-5 (<1-(α,α,α-Trifluor-o-tolyl)-cyclobutyl>-carbonyl)-harnstoff 
• 29786-63-8 <1-(α,α,α-Trifluor-o-tolyl)-cyclobutyl>-carbonylisocyanat 

Relevant academic research and scientific papers

Oxadiazole Amine Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same

The present invention relates to a novel compound having an activity of inhibiting histone deacetylase 6 (HDAC6), an optical isomer thereof or a pharmaceutically acceptable salt thereof, a use thereof for preparation of a drug for treatment, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing the same. The novel compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof according to the present invention has an activity of inhibiting histone deacetylase 6 (HDAC6), and is effective for preventing or treating HDAC6-related diseases, including infectious diseases; neoplasm; endocrine, nutritional and metabolic diseases; mental and behavior disorders; nerve disorders; eye and adnexa diseases; cardiovascular diseases; respiratory diseases; digestive organ diseases; skin and subcutaneous tissue diseases; musculoskeletal and connective tissue diseases; or congenital malformation, deformation and chromosomal abnormality.COPYRIGHT KIPO 2017

Propionamide compounds as antiinflammatory agents

The present invention relates to compounds of formula I: wherein R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof The invention also relates to methods of using the compounds of formula I a

Glucocorticoid receptor modulators as antiinflammatory agents

The present invention relates to compounds of formula I: wherein A, X, R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof. The invention also relates to methods of using the compounds of form